Chimera Biotec GmbH
Chimera Biotec’s core technologies are bioconjugates, i.e. chimeric molecules combining the advantages of nucleic acids and proteins. Chimera Biotec is dedicated to the development of high-performance, customer-specific innovations for protein and nucleic acid analysis.
Chimera manufactures conjugates of DNA and proteins, providing unique novel reagents with improved properties. Chimera’s research team combines interdisciplinary specialists of chemists and biologists, focussed on the development, optimization and application of the novel chimeric reagents.
http://www.chimera-biotec.com [ Detail ]
|
Pharmacelsus GmbH
Contract Research Organisation, test services, drug discovery. In vitro and vivo pharmacology, bio-analysis
http://www.pharmacelsus.de [ Detail ]
|
|
NanoBiotechnology